Facebook Linkedin Youtube X-twitter Instagram
Professional Syndicates Complex, Sharif Abdel Hamid Sharaf Street, 31, Amman, Jordan
About Jordan
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
Login
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
  • من نحن
    • تاريخ الجمعية
    • هيكل الجمعية
    • ادارة الجمعية
    • تطوع معنا
  • العضوية
    • طلب انتساب
    • الاعضاء المنتسبون
    • Types of memberships in the Society of Cardiologists
  • Home
  • نشاطات
  • مواد علمية
  • Health Education
  • جاليري
    • فيديو
    • صور
  • اتصل بنا
Uncategorized
webadmin May 29, 2025 0

Surgeons Report Favorable Outcomes for High-Risk TAVR Explant and SAVR Patients

Surgeons Report Favorable Outcomes for High-Risk TAVR Explant and SAVR Patients
Date: May 12, 2025 | Source: The Annals of Thoracic Surgery.
1. Background:
• When a TAVR valve fails, redo TAVR is not always possible. In such cases, surgical explant of the TAVR valve followed by surgical aortic valve replacement (SAVR) is often required—though it carries significant risks.
2. Study Overview (UAB Experience):
• Surgeons at the University of Alabama at Birmingham (UAB) analyzed data from 33 high-risk patients (mean age 75) who underwent TAVR explantation + SAVR.
• These patients were part of a larger group of 2,000+ who had previously undergone TAVR.
• Indications for explant included:
• Bioprosthetic degeneration
• Endocarditis
• Severe paravalvular leak
• Ventricular septal defect
• All patients were ineligible for redo TAVR per heart team evaluation.
3. Procedural Details:
• All surgeries were performed via median sternotomy, with standard bypass, myocardial protection, and explant techniques (e.g., “peel-away” or “roll” method).
• Only bioprosthetic SAVR valves were used.
• No Bentall procedures were needed; root repair was required in 3 cases.
4. Outcomes:
• 30-day survival: 94%
• 1-year survival: 81.4%
• 3-year survival: 61.6%
• Perioperative mortality: 6%
• Average hospital stay: 10 days
• The TAVR explant rate at UAB was 1.3%, in line with published data (0.5–2%).
5. Clinical Implications:
• Despite the high-risk nature of these patients, the team reported some of the best short- and mid-term survival results to date.
• Success was attributed to:
• Careful patient selection and optimization
• Surgical efficiency and simplicity
• Focused postoperative management
• Outcomes were worse when mitral surgery was combined with explant.
6. Conclusion:
• As TAVR volumes rise, surgical teams must adapt to the growing need for explantation procedures.
• Institutional experience and understanding of cohort-specific risk factors are key to improving safety and outcomes.
https://www.annalsthoracicsurgery.org/article/S0003-4975(25)00407-2/abstract
88 Views
9
First-in-Human Data on TTVR Device Shows Promising ResultsMay 29, 2025
AI Newswatch – Highlights from May 2025- Riding the AI Wave. How Businesses Are Benefiting from Trump’s Middle East visitMay 29, 2025

مقالات ذات صلة

Uncategorized

Medtronic Backs New Training Hub for cardiac intervention.

webadmin June 27, 2025
Uncategorized

Music Therapy in the ED: A Pain and Anxiety Reliever?

jordan heart July 6, 2025

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

احدث المقالات

  • ESC Leads Push for Stronger CE-Mark Evidence on High-Risk Devices
  • TAVR(TAVI in Europe)vs. SAVR —  Cardiologists, heart surgeons sound alarm over widespread use of TAVR in low-risk patients
  • Pediatric Cardiology: The LEAD Initiative — Universal Cholesterol Screening in Children Can Save Lives
  • Vericiguat in Heart Failure – VICTORIA vs VICTOR (ESC 2025)
  • Aspirin and Cancer Prevention

فئات

  • Health Education
  • Previous lectures and conferences
  • Uncategorized

Jordanian Cardiology Society

Jordanian Cardiology Society

Amman-Jordan

00962795001983

Working hours

From Sunday to Thursday

From nine in the morning until four in the afternoon

Important Links

Jordanian Cardiology Society

Research and studies

Medical articles

Login

Privacy Policy

Refund Policy

Cancellation Policy

Delivery Policy

Association Location

Copyright © 2024 Jordanian Cardiologists Association by WebAppRoots. All Rights Reserved.